A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis

Overview of attention for article published in Genome Medicine, May 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

So far, Dimensions has found 24 publications that cite this research output.

Article in Clinical and Experimental Ophthalmology (January 2024)

Article in Frontiers in Immunology (February 2023)

Article in Frontiers in Genetics (January 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.